Benchmark Holdings ( (GB:BMK) ) has issued an announcement.
Benchmark Holdings has completed the sale of its genetics business to Starfish Bidco, a subsidiary of Novo Holdings, for an enterprise value of £260 million. This transaction is expected to yield gross cash proceeds of approximately £194 million, with net cash proceeds of about £107.5 million after debt repayments. The sale aligns with Benchmark’s strategic focus, and further details on the use of proceeds will be provided in mid-April.
More about Benchmark Holdings
Benchmark Holdings is a leading aquaculture biotechnology company focused on sustainability in aquaculture. It offers products and solutions in genetics, advanced nutrition, and health to improve yield, growth, and animal health and welfare. The company operates globally, addressing major aquaculture species such as salmon, shrimp, sea bass, sea bream, and tilapia.
YTD Price Performance: -25.15%
Average Trading Volume: 214,479
Technical Sentiment Signal: Buy
Current Market Cap: £185.4M
For detailed information about BMK stock, go to TipRanks’ Stock Analysis page.